Cardiovascular Outcomes Observed with Ticagrelor versus Clopidogrel in Type 2 Diabetes Mellitus Patients with Acute Coronary Syndrome: A Meta-analysis

被引:0
作者
Zhiming Jiang
Le Liu
Pravesh Kumar Bundhun
机构
[1] The Fourth Hospital of Changsha,Department of Cardiology
[2] The Eighth Hospital of Changsha,Department of Cardiology
[3] Bruno Cheong Hospital,Department of Internal Medicine
来源
Diabetes Therapy | 2023年 / 14卷
关键词
Type 2 diabetes mellitus; Diabetes therapy; Ticagrelor; Clopidogrel; Percutaneous coronary intervention; Acute coronary syndrome; Antiplatelet therapy; Cardiovascular outcomes;
D O I
暂无
中图分类号
学科分类号
摘要
Type 2 diabetes mellitus (T2DM) is increasing all over the world, and is often associated with macrovascular complications including cardiovascular diseases (CVDs), leading to acute coronary syndrome (ACS).
引用
收藏
页码:387 / 399
页数:12
相关论文
共 48 条
[11]  
Menichelli M(2020)Comparison between Ticagrelor versus Clopidogrel in Long Term Outcomes of Taiwanese Diabetic Subjects with Acute Coronary Syndrome Undergoing Successful Revascularization: From TSOC ACS-DM Registry Medicine (Baltimore) 99 835-1988
[12]  
Ndrepepa G(2020)Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study Circulation 142 1981-2273
[13]  
Kastrati A(2016)Clopidogrel versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated with Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients) Circulation 134 2261-1320
[14]  
Menichelli M(2017)Antithrombotic Potency of Ticagrelor versus Clopidogrel in Type-2 Diabetic Patients with Cardiovascular Disease Thromb Haemost 117 1309-undefined
[15]  
Stang A(2013)Consensus and Update on the Definition of on-Treatment Platelet Reactivity to Adenosine Diphosphate Associated with Ischemia and Bleeding J Am Coll Cardiol 62 undefined-undefined
[16]  
Page MJ(2019)Ticagrelor in Patients with Stable Coronary Disease and Diabetes N Engl J Med 381 undefined-undefined
[17]  
McKenzie JE(undefined)undefined undefined undefined undefined-undefined
[18]  
Bossuyt PM(undefined)undefined undefined undefined undefined-undefined
[19]  
He P(undefined)undefined undefined undefined undefined-undefined
[20]  
Luo X(undefined)undefined undefined undefined undefined-undefined